JTI Launches Heated Tobacco Product "Ploom" in Philippines

Nov.12.2024
JTI Launches Heated Tobacco Product "Ploom" in Philippines
JTI introduces new heated tobacco product "Ploom" in the Philippines, aiming to expand product portfolio and market influence.

Japan Tobacco International (JTI) has announced the launch of their heated tobacco product "Ploom" in the Philippines to expand their product portfolio in the country, according to Philstar's report on November 12.

 

JTI Launches Heated Tobacco Product
Japan Tobacco International launched the heated tobacco product "Ploom" in the Philippines | Image Source: JTI Official Website

 

"The year 2024 has been a landmark one for JTI in the market, so it is a very exciting time for us. Having been awarded Top Employer for the third year in a row, we are also the fastest growing tobacco company in the Philippines. With the introduction of Ploom, it is another remarkable milestone as we are proud to be the first in Asia, outside of Japan, to launch the brand – a sign of our commitment to continue building on our expanding market presence,” JTI Philippines general manager John Freda said.

 

The company added that it aims to build a strong consumer base for Ploom in the Philippines and further drive the adoption of heated tobacco products.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Guernsey's QuitVape program for youth e-cigarette cessation to end at the end of the month
UK Guernsey's QuitVape program for youth e-cigarette cessation to end at the end of the month
QuitVape e-cigarette quitting service for teens in Guernsey to end this month, after six-month trial period.
Dec.29 by 2FIRSTS.ai
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
Warner Robins City Council Pauses New Vape Shop Licensing
Warner Robins City Council Pauses New Vape Shop Licensing
The Warner Robins City Council has unanimously approved a six-month moratorium on issuing new licenses for retail liquor package stores and businesses primarily selling vape, CBD, tobacco, and related products. The pause will remain in effect until June 2, 2026, unless further action is taken, while pending applications are exempt.
Dec.16 by 2FIRSTS.ai
Wisconsin Fines Vape Retailers Nearly $13 Million for Selling Unapproved Products
Wisconsin Fines Vape Retailers Nearly $13 Million for Selling Unapproved Products
The state of Wisconsin has fined one retailer nearly USD 12.44 million and another USD 450,000 for violating the state’s new vape sales law, which took effect in September and restricts sales to an approved list of products.
Dec.11 by 2FIRSTS.ai
2FIRSTS Data Insight|China’s Vape Exports to the U.S. Hit a Record $590 Million: A Peak Driven by Enforcement Cycles, Not Real Demand
2FIRSTS Data Insight|China’s Vape Exports to the U.S. Hit a Record $590 Million: A Peak Driven by Enforcement Cycles, Not Real Demand
China’s vape exports to the U.S. surged to a record $590 million in October 2025—nearly double the usual monthly level and pushing the U.S. share above 50% of China’s global shipments.But the spike was not driven by demand. Instead, it reflected a temporary release created by tightened U.S. enforcement, a collapsed logistics pathway, and a bullwhip-style surge in replenishment.The peak signals more volatility ahead, not recovery.
Special Report
Nov.24
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai